Friday 6 November 2026 Export VRTX’s income statement to Excel — free account

Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $12.0 billion, up 8.90% from fiscal 2024.

Revenue: +11.9%
EPS: −39.2%
Free cash flow: −52.1%

Quarter to September 2026, against a year earlier

547.43 4.93 +0.91%

Follow VRTX

Alert me

Market cap: $137.5B
P/E: 34.6×
Fwd P/E: 33.2×
Dividend yield: —
F-score: 8/9
Altman Z: 12.06
Beneish M: −2.17
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
ROE Full definition →	+8 more TTM periods Free account	22.54%	24.20%	23.54%	20.80%
Piotroski F-Score Full definition →		8	8	6	3
ROA Full definition →		16.41%	17.58%	17.12%	13.81%
ROIC Full definition →		21.63%	24.15%	24.09%	14.86%
Return on Tangible Assets Full definition →		44.62%	45.87%	42.89%	47.35%
Average Days of Receivables Full definition →		62.43	59.63	61.89	65.13
Free Cash Flow per Share Full definition →		12.49	14.60	14.96	12.63
Free Cash Flow Full definition →		3,193.80	3,710.30	3,796.10	3,202.30
Capital Expenditures Full definition →		(437.60)	(530.30)	(496.80)	(492.30)
Other line items
Cash ROIC Full definition →		12.64%	13.94%	13.51%	10.43%
Accounts Receivable Turnover Full definition →		6.55	6.43	6.25	6.08
Accounts Payable Turnover Full definition →		3.78	3.60	4.04	4.20
Inventory Turnover Full definition →		1.14	1.08	1.08	0.97
Average Days of Payables Full definition →		102.05	106.24	88.93	92.04
Days of Inventory on Hand Full definition →		372.85	383.59	365.48	437.30
Tax Rate Full definition →		(0.15)	(0.16)	(0.16)	(0.16)
Research and Development Expense of Revenue Full definition →		32.58%	31.85%	31.04%	32.81%
Selling, General and Administrative Expense of Revenue Full definition →		14.61%	15.14%	15.95%	18.58%
Share Based Compensation of Revenue Full definition →		5.72%	5.62%	5.47%	5.16%
Interest Coverage Full definition →		208.67	—	—	81.20
Operating CF/Net income Full definition →		0.92	0.98	0.97	0.93
Depreciation/Fixed assets Full definition →		0.14	0.14	0.13	0.14
Capex/Depreciation Full definition →		(2.09)	(2.44)	(2.24)	(2.07)
Revenue per Share Full definition →		46.94	48.08	49.61	51.09
Operating CF per Share Full definition →		14.20	16.69	16.92	14.57
Capex per Share Full definition →		(1.71)	(2.09)	(1.96)	(1.94)
Capex to Sales Full definition →		0.04	0.04	0.04	0.04

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly